CM Life Sciences II stock rallies for fourth day on SomaLogic deal

CM Life Sciences II Inc. (Nasdaq:CMIIU) rallied for the fourth day as Wall Street continued to endorse the SPAC’s plan to buy SomaLogic at a $1.2 billion valuation.
Read More